Unraveling the secrets in human DNA has reshaped medicine in ways that were unimaginable a generation ago. From detecting cancer risk before symptoms appear to guiding which medications a patient will respond to, genomic medicine is moving clinical care from guesswork to precision.
The University of West Florida’s online Bachelor of Science (B.S.) in Clinical Lab Sciences – Medical Lab Technician to Medical Lab Scientist (MLT to MLS) program prepares working laboratory professionals to take on this expanding role — equipping them with the clinical skills that genomic medicine depends on. Genomic screening will continue to grow, and medical lab scientists will be essential in making it work.
What Is Genomic Medicine?
Genomic medicine is the practice of using a person’s genomic information as part of their clinical care to predict, diagnose, treat, and prevent disease. According to the National Human Genome Research Institute (NIH), it is already making an impact in oncology, pharmacology and the diagnosis of rare diseases. Unlike traditional medicine, which responds to symptoms, genomic medicine enables a personalized medicine approach that tailors decisions to each patient’s unique genetic makeup before disease takes hold.
One of the clearest examples of this is cancer treatment. NIH notes that oncology is at the leading edge of incorporating genomics, with genetic and genomic markers now routinely included in cancer screening and used to guide tailored treatment strategies. Testing for epidermal growth factor receptor (EGFR) mutations in lung cancer, for instance, transformed treatment because EGFR only responds to certain drugs — making genomic testing a standard step in lung cancer care. Genomic data also drives pharmacogenomics — the study of how genes affect a person’s response to medications — allowing physicians to choose the right drug at the right dose from the start.
What Happens When You Get Your Genome Sequenced?
Whole genome sequencing begins with extracting DNA from a patient’s tissue — typically blood or saliva. Medical lab scientists prepare the DNA through a series of chemical and enzymatic reactions, converting it into a format that sequencing machines can read. During the sequencing process, each DNA molecule emits a light signal. A camera detects each signal, and because the four DNA bases — A, G, T and C — each produce a unique signature, analysts can decode the complete sequence for every cluster of DNA.
Once sequencing is complete, physicians gain access to a detailed map of a patient’s genetic variants. That map can reveal whether a patient carries the BRCA2 gene mutation linked to breast and ovarian cancer, confirm the presence of genes associated with cystic fibrosis or Huntington’s disease or show how the patient’s body metabolizes specific medications. The resulting picture of DNA sequencing data equips care teams to make proactive, targeted decisions rather than waiting for symptoms to emerge.
How Does Genomic Medicine Prevent and Treat Diseases?
Genomic medicine is changing disease prevention by replacing guesswork with direct analysis of a patient’s DNA or RNA. Instead of relying on general risk factors, physicians can use genomic screening to find diseases before symptoms develop — reducing healthcare costs and supporting earlier, more effective treatment. Genetic testing is most closely associated with identifying single-gene disorders such as cystic fibrosis, Huntington’s disease and sickle cell anemia, as well as determining whether a patient carries gene variants that raise their risk for hereditary cancers.
When a genetic test reveals elevated cancer risk, the American Cancer Society outlines several risk management options: lifestyle changes, chemoprevention, prophylactic surgery and early detection screening. For example, patients who test positive for mutations in both BRCA1 and BRCA2 genes face a significantly higher risk of breast and ovarian cancer and may choose preventive surgery based on those results.
Genomic medicine also shapes treatment decisions. Mayo Clinic notes that physicians can use genetic data to determine dosages and select medications best suited to a patient’s genetic profile — a direct application of pharmacogenomics. Polygenic risk scores, which analyze thousands of genetic variants at once, extend this approach to common conditions like heart disease and type 2 diabetes, helping clinicians intervene before a condition develops. Patients can also work with a genetic counselor to interpret results and build a personalized prevention plan.
Genetic testing is perhaps most valuable in newborns. When analysis reveals genetic or metabolic abnormalities at birth, treatment can begin immediately — before symptoms cause lasting harm. Genomic research is also expanding into the role of microbiomes in disease, exploring how the trillions of microbes living in the human body influence health outcomes and treatment response — learn more in how gut microbiomes affect our health.
What Does the Future of Genomic Medicine Look Like?
As genomic testing becomes more affordable and widespread, it is moving toward standard practice in clinical care. The medical community is already seeing results. Routine genetic testing has been shown to produce better outcomes across a range of conditions, including in children with cardiomyopathies where testing can identify a genetic cause even in families with no prior history of the disease.
The next phase of genomic medicine involves integrating whole genome sequencing into routine care — not just for rare diseases or cancer, but for conditions ranging from heart disease to infectious illness. Precision medicine is expanding into molecular diagnostics, where lab-based analysis of genetic material guides treatment at the cellular level. Microbes, too, are central to this future: lab scientists are uncovering how trillions of microscopic organisms shape human health in ways that could lead to breakthroughs in drug development and disease treatment. For medical lab scientists, this shift means growing demand for professionals who can run complex genetic assays, interpret genomic data, and support clinical decision-making at every stage of care.
What Are the Ethical Considerations in Genetic Testing?
Genetic testing offers real benefits, but it also raises questions that patients and providers must weigh carefully. One challenge is uncertainty — a positive screening result for breast cancer risk cannot predict whether cancer will actually develop or how quickly. A negative result, meanwhile, does not guarantee that other causes of disease are absent. For some patients, those unknowns produce significant stress, regardless of the outcome.
Access and discrimination are also concerns. If a physician identifies serious genetic risk in a patient who cannot afford treatment, the value of that information becomes complicated. The National Human Genome Research Institute notes that the Genetic Information Nondiscrimination Act (GINA) prohibits health insurers and most employers from using genetic information to make decisions about coverage or employment — a protection designed to encourage people to undergo testing without fear of consequences. Still, GINA has limits: it does not cover life insurance, disability insurance or employers with fewer than 15 employees. As with any medical decision, patients must weigh the potential benefits of early knowledge against personal, financial and emotional risks.
What Careers Are Available in Genomic Medicine and Medical Lab Science?
Genomic medicine depends on a skilled team — from genetic counselors and physicians to the medical laboratory scientists who perform and interpret the tests that make it all possible. Medical lab scientists run the full range of clinical laboratory procedures involved in genomic analysis: molecular diagnostics, hematology, clinical chemistry, and diagnostic microbiology. They prepare samples, operate sequencing equipment, and validate results that physicians use to guide patient care.
UWF’s Clinical Lab Sciences – MLT to MLS online program prepares working medical laboratory technicians (MLTs) to advance into this role. The curriculum covers genetic analysis of bacterial and viral genomes, interpretation of laboratory results for diseases like cystic fibrosis, and the genetic alterations linked to many forms of leukemia. Graduates are qualified to sit for the American Society for Clinical Pathology (ASCP) national exam and pursue careers as medical lab scientists, laboratory managers or biotechnologists in settings where genomic medicine is becoming the standard of care.
Explore UWF’s Clinical Lab Sciences – MLT to MLS online program and build the laboratory expertise that genomic medicine demands.
About UWF’s Online Clinical Lab Sciences – MLT to MLS Program
The University of West Florida’s online Clinical Lab Sciences – MLT to MLS program is designed for working medical laboratory technicians who hold ASCP, AMT or AAB certification and want to advance to the medical laboratory scientist level. The program covers the full range of clinical laboratory disciplines — including hematology, molecular diagnostics, clinical chemistry, diagnostic microbiology and immunohematology — along with clinical genetics, pathophysiology and laboratory management.
Graduates are prepared to sit for the ASCP national board exam and pursue careers in hospitals, independent labs, research settings and genomic medicine facilities where advanced testing expertise is in growing demand. Learn more about UWF’s Clinical Lab Sciences – MLT to MLS online program.
